Inhibikase Therapeutics (IKT) Misses Q1 EPS by 15c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: IKT) | Delayed: 1.57 +0.09 (6.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.48 | 52 Week High | $ | |||
| Open | $1.56 | 52 Week Low | $ | |||
| Day High | $1.60 | P/E | N/A | |||
| Day Low | $1.51 | EPS | $ | |||
| Volume | 675,944 | |||||
